Healthcare Industry News: Elekta
News Release - April 21, 2006
Elekta Receives Multiple Elekta Synergy(R) Orders From AustraliaSTOCKHOLM, Sweden--(HSMN NewsFeed)--April 21, 2006--Elekta, a world leader in advanced radiation therapy, comprehensive cancer management and non-invasive treatment of brain disorders, today announced two new Elekta Synergy® orders from North Coast Area Health Service in New South Wales, Australia. These orders together with recent orders from Austin Health Hospital in Heidelberg, Victoria and Townsville Hospital, Queensland, are proof of Elekta's increasing impact on cancer care in Australia and represents in total an order value in excess of AUD 10 million.
The concept of image guided radiation therapy (IGRT) and Elekta's 3D X-ray Volume Imaging is rapidly gaining clinical acceptance all over the world. Not less so in Australia where for example the recent 9th International Workshop on Electronic Portal Imaging, held in Melbourne, April 8-12, featured three presentations on IGRT on Elekta Synergy.
The most recent Australian orders for Elekta's pioneering IGRT technology come from clinics located in Coffs Harbour and Port Macquarie in New South Wales, both part of the North Coast Area Health Service (NCAHS). These new customers to Elekta also invested in oncology information management systems from IMPAC Medical Systems - an Elekta company - including MOSAIQ(TM), the world's most advanced electronic medical record (EMR) system for oncology clinics.
In March, Elekta also received orders for advanced digital linear accelerators from Austin Health Hospital in Heidelberg, Victoria, also equipped with IGRT technology and the MOSAIQ EMR system, and from Townsville Hospital in Queensland. These systems are already delivered.
"We chose Elekta since 3D X-ray Volume Imaging on Elekta Synergy is now very well established and has been proven clinically at so many sites throughout the world", says Mr. Dominic Au-Yeung, Manager of Radiation Oncology at Austin Health Hospital, and continues; "at Austin, we are looking forward to the new systems being installed in June this year".
Elekta have recently also installed IMPAC's electronic medical record system at Radiation Oncology Victoria (ROV) in Melbourne, which is now successfully up and running in all four of their current centers and installed at the soon to be opened fifth center, all integrating the operations and treatment process on linear accelerators from different suppliers.
"We are very pleased with the recent development in Australia where Elekta now holds a strong position. We can offer a comprehensive solution in the fight against cancer from the most innovative digital linear accelerator on the market to the best software solution for oncology information management, a combination very well adapted to today's customer demand", summarizes Brendan J. Vahey, Managing Director and head of Elekta's Business Unit Australia.
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Clinical solutions include among others Leksell Gamma Knife® for non-invasive treatment of brain disorders and Elekta Synergy® for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group is the world's largest supplier of oncology software.
Elekta's systems and solutions are used at over 3,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approx. 1850 employees, Elekta's corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta, please visit www.Elekta.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.